Glucose point-of-care testing in the neonatal intensive care unit, as the basis for informing clinical decision-making and treatment of neonatal hypoglycemia, has been extensively adopted as a preferred clinical tool, given its ease of use and minimal blood volume requirement to obtain a timely bedside glucose result.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile